Durgical
EN
Open the app

The skin of transplant and immunosuppressed patients

  • Topic

The drugs that protect a transplanted organ also weaken the skin's defence against cancer and infection. Skin cancer is the commonest cancer after transplant.

Updated

See it in 3D: Skin

What it is

Organ transplant recipients and others on long-term immunosuppression have a far higher risk of skin cancer, above all cutaneous squamous cell carcinoma, which becomes many times more common than in the general population, appears in multiples and behaves more aggressively. Basal cell carcinoma, melanoma, Merkel cell carcinoma and Kaposi sarcoma (HHV-8) are also more frequent. Viral infections are widespread and persistent: warts (HPV), molluscum, severe or disseminated herpes simplex and zoster. Bacterial, fungal and mycobacterial infections may appear as bland nodules because inflammation is muted. The drugs themselves change the skin: corticosteroids thin it and cause acne and striae, ciclosporin causes excess hair and gum overgrowth, mTOR inhibitors slow wound healing and cause mouth ulcers, and azathioprine and voriconazole increase sun sensitivity and skin cancer. After stem cell transplant, graft-versus-host disease is a major skin problem.

Key facts

  • Squamous cell carcinoma is the most frequent cancer after solid organ transplant; the ratio to basal cell carcinoma is reversed compared with the general population.
  • Highest risk: heart and lung recipients (deepest immunosuppression), fair skin, years of sun exposure, more years since transplant, previous skin cancer.
  • Warts are numerous and stubborn; a wart-like lesion that grows quickly, hurts or bleeds may be squamous cell carcinoma.
  • Kaposi sarcoma: purple patches, plaques or nodules on legs or mucosa; may regress when immunosuppression is reduced.
  • Infections: zoster in several dermatomes or disseminated, chronic herpes ulcers, extensive tinea, nodules from deep fungi, nocardia or atypical mycobacteria.
  • Drug effects: thin skin and acne (corticosteroids), excess hair and gum overgrowth (ciclosporin), poor wound healing and mouth ulcers (mTOR inhibitors), sun sensitivity (azathioprine, voriconazole).

Step by step

  1. Calcineurin inhibitors, antimetabolites and corticosteroids switch off T-cell surveillance.
  2. UV mutations in keratinocytes accumulate over years without being cleared.
  3. Some drugs add damage: azathioprine sensitises DNA to UVA, voriconazole is phototoxic, calcineurin inhibitors impair DNA repair.
  4. Oncogenic viruses replicate unchecked: beta-HPV in sun-damaged skin, HHV-8 in Kaposi sarcoma, Merkel cell polyomavirus.
  5. Result: field damage with many actinic keratoses, warts and squamous cell carcinomas, usually starting some years after transplant.
  6. mTOR inhibitors (sirolimus, everolimus) are anti-proliferative, so switching to them can reduce new squamous cell carcinomas.

A new lesion in an immunosuppressed patient: what it may be

LesionThink ofNext step
Growing scaly or crusted papule on face, scalp or handsSquamous cell carcinomaExcision with margins
Many warts on hands and faceHPV warts, possible early carcinomaTreat; biopsy any atypical one
Purple patches or nodulesKaposi sarcomaBiopsy; HIV test; review immunosuppression
Fast-growing pink-red firm nodule on sun-exposed skinMerkel cell carcinomaUrgent excision biopsy
Painful vesicles in several dermatomes, chronic ulcerHerpes zoster or herpes simplexPCR; prompt antiviral
Bland nodule or ulcer, sometimes with feverNocardia, deep fungi, atypical mycobacteriaBiopsy for histology and tissue culture
Rash of palms, soles and ears after stem cell transplantAcute graft-versus-host diseaseBiopsy; transplant team at once

In clinical practice

  • Examine the whole skin before transplant and then regularly for life, more often in high-risk patients; teach self-examination.
  • Strict sun protection all year (clothing, hat, sunscreen, shade); in Colombia UV is high all year, especially at altitude.
  • Field treatment of actinic keratoses reduces the load of lesions that can become carcinomas.
  • For patients with many squamous cell carcinomas, the transplant team may reduce immunosuppression or switch to an mTOR inhibitor; oral acitretin or nicotinamide may be added for prevention.
  • The same rules apply, to a lesser degree, to people with HIV, long-term corticosteroids, biologics or other immunosuppressants.

Next step

  • Biopsy early any new lesion that grows, bleeds or hurts; the threshold is lower than in other patients.
  • Nodules or ulcers, especially with fever: biopsy for histology and tissue culture for bacteria, mycobacteria and fungi; PCR for herpes viruses.
  • Refer to dermatology for regular skin surveillance, and refer urgently any rapidly growing carcinoma, suspected Merkel cell carcinoma or Kaposi sarcoma.
  • Any change in immunosuppression is agreed with the transplant team, who weigh the risk of rejection.

Common traps

  • Skin cancer after transplant is mostly basal cell carcinoma, as in everyone else: the ratio reverses and squamous cell carcinoma dominates, often multiple and aggressive.
  • A wart in a transplant patient is harmless: warts and early squamous cell carcinoma look alike; a lesion that grows, bleeds or hurts needs biopsy.
  • Infection always looks red, hot and tender: immunosuppression mutes inflammation, so a bland nodule may be a deep fungal or mycobacterial infection.
  • The dermatologist can stop the immunosuppressant: changes are made with the transplant team because the organ may be rejected.

Test yourself

Think of the answer, then tap the question to see it.

Why do kidney transplant recipients develop many squamous cell carcinomas years after transplant?

Immunosuppression removes T-cell surveillance of UV-mutated and HPV-infected keratinocytes, and some drugs add DNA damage; mutated cells survive and accumulate into cancers.

A heart transplant patient keeps developing squamous cell carcinomas. What can the transplant team change?

Lower the immunosuppression or switch the calcineurin inhibitor to an mTOR inhibitor, which is anti-proliferative; acitretin may be added as chemoprevention.

A lung transplant patient has a painless red nodule on the leg and low-grade fever. What is the next step?

Biopsy with tissue culture for bacteria, mycobacteria and fungi: muted inflammation makes nocardia, deep fungi or mycobacteria look bland.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of dermatology

Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.

Sources: Evaluation and Treatment of Skin Cancer in Patients With Immunosuppression (StatPearls Publishing (NCBI Bookshelf), 2024); Skin Cancer (StatPearls Publishing (NCBI Bookshelf), 2024); Kaposi Sarcoma (StatPearls Publishing (NCBI Bookshelf), 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.